Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Po-Li Wei

24PUBLICATIONS
28CO-AUTHORS
Medical biotechnology not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

Sort by Publication Date:
|Mar 04, 2025
Correction: Leung et al. Preclinical Identification of Sulfasalazine's Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. <i>Biomedicines</i> 2022, <i>10</i>, 377.

Wai-Hung Leung, Jing-Wen Shih, Jian-Syun Chen

|Jan 11, 2024
Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting <i>CD24</i>/<i>CTNNB1</i>/<i>SOX4</i>-Centered Signaling Hub.

Jing-Wen Shih, Alexander T H Wu, Ntlotlang Mokgautsi

|Oct 28, 2023
CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer.

Cheng-Chin Lee, Kuei-Yen Tsai, Ai-Wei Lee

|Jul 29, 2023
2,3,5,4'-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy.

Kuei-Yen Tsai, Po-Li Wei, Cheng-Chin Lee

|Jul 26, 2023
Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer.

Kuei-Yen Tsai, Yu-Jia Chang, Chien-Yu Huang

|Jul 14, 2023
Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis.

Chien-Yu Huang, Po-Li Wei, Uyanga Batzorig

Pageof 4

Frequent Collaborators

9 joint publications

Yu-Jia Chang

4 joint publications

Jung-Chun Lin

4 joint publications

Uyanga Batzorig

3 joint publications

Chin-Sheng Hung

3 joint publications

Yan-Jiun Huang

3 joint publications

Ntlotlang Mokgautsi

3 joint publications

Jing-Wen Shih

2 joint publications

Jian-Syun Chen

2 joint publications

Cheng-Yang Lee

2 joint publications

Ching-Sheng Hung

Frequent Collaborators

9 joint publications

Yu-Jia Chang

4 joint publications

Jung-Chun Lin

4 joint publications

Uyanga Batzorig

3 joint publications

Chin-Sheng Hung

Top Related Videos

Regulation of Hormone Secretion
01:19

Regulation of Hormone Secretion

6.0K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

13.8K
See more related videos

Top Related Videos

Regulation of Hormone Secretion
01:19

Regulation of Hormone Secretion

6.0K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

13.8K
See more related videos